Home / Stocks / SPRY

SPRY insider trading

ARS Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-11-14Chakma Justin
Chief Business Officer
Sold136,380$8.86$1.2M
2025-07-01DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
10% owner
Sold740,149$18.46$13.7M
2025-05-22Fitzpatrick Alexander A
Chief Legal Officer
Sold102,969$14.10$1.5M
2025-05-22SAUNDERS BRENT L
Director
Sold120,000$14.25$1.7M
2024-12-13Chakma Justin
Chief Business Officer
Sold117,333$12.27$1.4M
2024-12-04Shawver Laura
Director
Sold184,327$13.41$2.5M
2024-11-13DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
10% owner
Sold447,264$18.15$8.1M

See SPRY on the chart

Every insider buy and sell for SPRY plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.